Cholinergic antagonist patch
AssigneeCaleb Pharmaceuticals, Inc.
InventorsWan-Yan Lin, Shu-Juan Chen, Chao-Wei Liao, Chien-Hsin D. Cheng
Life of this patent
Estimating the term…
Loading patent…
AssigneeCaleb Pharmaceuticals, Inc.
InventorsWan-Yan Lin, Shu-Juan Chen, Chao-Wei Liao, Chien-Hsin D. Cheng
Estimating the term…
Scopolamine is a folksy cholinergic antagonist, and is used by parasympathetic nerves in autonomic nervous neurons as an anti-motion sickness drug or an anti-emesis drug. Since the human body most effectively absorbs this drug through the postauricular skin, the drug is administered by postauricular transdermal resorption patch. The penetrability of drug is increase by adding a dermal penetrative enhancer, because the penetration ability of patch-administered drugs is usually decreased by the penetrative blockade at dermal horny layers. The present invention discloses a penetration enhancer to increase dermal absorption and penetration of the cholinergic antagonist. The present invention finds that polyethylene and amide enhance penetration, about 2.2-2.8 fold. In accordance with the present invention, a penetration enhancer is added to the formulations of transdermal patch to increase the human body's absorption of scopolamine.
A formulation for a cholinergic antagonist patch, comprising:
A formulation for a cholinergic antagonist patch, comprising:
A formulation for a cholinergic antagonist patch, comprising:
Dependencies are inferred from the claim text.